How Celery Can Transform Your Health: Medicinal Uses and More!

Pallavi Madhiraju- July 20, 2024 0

Celery, known scientifically as *Apium graveolens*, belongs to the Apiaceae or Umbelliferae family. This biennial herb has been revered for its medicinal properties and culinary ... Read More

Understanding Arthritis: A deep dive into causes, types, and home remedies

Pallavi Madhiraju- March 9, 2024 0

Arthritis, a term that encompasses over a hundred different conditions affecting joints and connective tissues, presents a significant health challenge across the globe. Characterized by ... Read More

Zydus Lifesciences’ Diclofenac Sodium and Misoprostol Tablets gets FDA final approval

Pallavi Madhiraju- June 18, 2023 0

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets ... Read More

Dr. Reddy’s Tocilizumab biosimilar shows promising results in phase 1 trial

Pallavi Madhiraju- June 5, 2023 0

Dr. Reddy's Laboratories, an Indian pharmaceutical company, announced a significant milestone as its tocilizumab biosimilar candidate, DRL_TC, successfully met primary and secondary endpoints in a ... Read More

Home remedies for Arthritis: Natural ways to manage joint inflammation

Pallavi Madhiraju- May 28, 2023 0

Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies ... Read More

Gilead Sciences partners with EVOQ Therapeutics on immunotherapies

Raghuram Kadari- January 4, 2023 0

American biopharma major Gilead Sciences and immunotherapy company EVOQ Therapeutics have entered into a partnership to develop and market immunotherapy products. Under the collaboration and ... Read More

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

pallavi123- September 13, 2022 0

Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is ... Read More

Strides Pharma gets FDA approval for Cyclosporine Softgel Capsules

pallavi123- August 3, 2022 0

Strides Pharma Science said that its stepdown fully-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has secured approval from the US Food and Drug Administration ... Read More

Lupin rolls out generic version of Ibuprofen and Famotidine Tablets in US

pallavi123- September 20, 2021 0

Lupin Limited said that it has rolled out the authorized generic version of Horizon Medicines’ Duexise (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg. Ibuprofen and ... Read More

Gilead, Galapagos bag Jyseleca EC approval for rheumatoid arthritis

pharmanewsdaily- September 27, 2020 0

Jyseleca EC approval : Gilead Sciences and Galapagos have secured marketing authorization for Jyseleca (filgotinib 200 mg and 100 mg tablets) from the European Commission ... Read More